Advanced search
Publication Cover
OncoImmunology Volume 10, 2021 - Issue 1
Submit an article Journal homepage
2,741
Views
8
CrossRef citations to date
0
Altmetric
Brief Report

Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model

Sonia Domingos-Pereiraa Department of Urology, Lausanne University Hospital and University of Lausanne, Lausanne, SwizterlandView further author information
,
Vincent Rohb Departmentof Otolaryngology–Head and Neck Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, SwizterlandView further author information
,
Agnès Hiou-Feigeb Departmentof Otolaryngology–Head and Neck Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, SwizterlandView further author information
,
Gabriele Gallivertic Swiss Institute for Experimental Cancer Research, School of Life Sciences, EPFL, Lausanne, SwitzerlandView further author information
,
Christian Simonb Departmentof Otolaryngology–Head and Neck Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, SwizterlandView further author information
,
Genrich V. Tolstonogb Departmentof Otolaryngology–Head and Neck Surgery, Lausanne University Hospital and University of Lausanne, Lausanne, SwizterlandView further author information
&
Denise Nardelli-Haefligera Department of Urology, Lausanne University Hospital and University of Lausanne, Lausanne, SwizterlandCorrespondence[email protected]
View further author information
 show all
Article: 1912473 | Received 15 Feb 2021, Accepted 31 Mar 2021, Published online: 13 Apr 2021

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Yue Zhang, Faliang Ren, Bing Ni, Tao Jing & Jun Tang. (2021) Tumor targeting nanoparticle E749-57-HSP110-RGD elicits potent anti-tumor immune response in a CD8-dependent manner in cervical cancer-bearing mouse model. Human Vaccines & Immunotherapeutics 17:10, pages 3529-3538.
Read now

Articles from other publishers (7)

Fuming Liang, Qing You, Hongjiang Ye, Wenqiao Fu, Xiaopeng Ma, Jiahe Tan, Yinrui Ma, Chen Wang, Yanlian Yang, Zhaohui He & Ling Zhu. (2023) Nanomaterials for visualized tumor surgical navigation and postoperative recurrence inhibition. Nano Research.
Crossref
Yunting Shao, Peng Wang, Yunji Zheng, Hongtu Cui, Zhangrong Lou, Shanhu Li, Fang Huang & Chengjun Wu. (2023) A replicative recombinant HPV16 E7 expression virus upregulates CD36 in C33A cells. Frontiers in Microbiology 14.
Crossref
Qian‐Ting Wang, Yi‐Xuan Liu, Jie Wang & Hao Wang. (2023) Advances in Cancer Nanovaccines: Harnessing Nanotechnology for Broadening Cancer Immune Response. ChemMedChem 18:13.
Crossref
Qiang Xu, Ye Chen, Yuan Jin, Zhiyu Wang, Haoru Dong, Andreas M. Kaufmann, Andreas E. Albers & Xu Qian. (2022) Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer. Viruses 14:12, pages 2824.
Crossref
Chenhang Yu, Qiang Li, Yu Zhang, Zhi-Fa Wen, Heng Dong & Yongbin Mou. (2022) Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma. Frontiers in Cell and Developmental Biology 10.
Crossref
Valentina Foglizzo & Serena Marchiò. (2022) Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy. Cancers 14:10, pages 2473.
Crossref
Zhe Sun, Xiaodong Sun, Zhanwei Chen, Juan Du & Yihua Wu. (2021) Head and Neck Squamous Cell Carcinoma: Risk Factors, Molecular Alterations, Immunology and Peptide Vaccines. International Journal of Peptide Research and Therapeutics 28:1.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.